Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
FundaMental Pharma chosen among twelve companies to showcase its groundbreaking TRD candidate, FMP374, at the Bio-Neuroscience Conference.
-
LOS ANGELES, Feb. 12, 2026 (GLOBE NEWSWIRE) -- via IBN -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) and Sapu Bioscience today announced key advancements in its global intellectual...
-
DALLAS and FORT WORTH, Texas, Jan. 27, 2026 (GLOBE NEWSWIRE) -- U.S. Neurology Associates (USNA), a physician services organization dedicated to enhancing community-based neurology care, today...
-
Acquisition adds further specialist biostatistics, data management, and medical writing expertise to Evestia Clinical’s full-service offering and strengthens its presence in Germany and across Europe ...
-
Sevaro appoints Carl Dugart as CTO and Vineet Agrawal as Head of Growth to accelerate AI‑driven specialty care.
-
Toronto, Ontario, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Toronto, Ontario, January 23, 2026 A new study in the Journal of Neurotrauma offers the first real-world solution to a long-standing problem...
-
MELBOURNE, Australia and SAN FRANCISCO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to...
-
BOSTON, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3...
-
Omniscient secures new AMA CPT® code for connectomic analysis, validating Quicktome’s clinical utility in brain care and advancing reimbursement.
-
WASHINGTON, Jan. 12, 2026 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Spear Bio, a biotechnology company pioneering wash-free ultrasensitive...